These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 4310923)

  • 21. Effect of interferon treatment on the tumour-specific antibody response of BALB-c mice infected with Rauscher virus.
    Tóth FD; Váczi L; Berencsi C
    Acta Microbiol Acad Sci Hung; 1971; 18(2):109-12. PubMed ID: 4337368
    [No Abstract]   [Full Text] [Related]  

  • 22. [Isolation of 7S-immunoglobulins (IgG), detected in spleen cells and sera of mice in the early stages of Rauscher leukemia].
    Ter-Grigorov VS; Dzagurov SG; Dorfman NA; Shevelev BI
    Biull Eksp Biol Med; 1974 Nov; 78(11):82-5. PubMed ID: 4614878
    [No Abstract]   [Full Text] [Related]  

  • 23. Viral leukemogenesis in immunologically and hematologically altered mice.
    Sinkovics JG; Ahearn MJ; Shirato E; Shullenberger CC
    J Reticuloendothel Soc; 1970 Nov; 8(5):474-92. PubMed ID: 4319518
    [No Abstract]   [Full Text] [Related]  

  • 24. Autoimmune disease in New Zealand Black mice infected with Rauscher leukemia virus.
    Siegel BV; Morton JI
    J Natl Cancer Inst; 1970 Jul; 45(1):189-93. PubMed ID: 4915456
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunogenicity of splenocytes, associated with temporal exposition of D-galactosyl residues, in Rauscher leukemia.
    Novichenko NL
    Arch Geschwulstforsch; 1984; 54(4):279-84. PubMed ID: 6497576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Graft versus leukemia: effect of phytohemagglutinin-stimulated and normal spleen cells on Rauscher disease.
    Lair SV; Lozzio BB
    J Natl Cancer Inst; 1974 Oct; 53(4):1165-8. PubMed ID: 4427392
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of pyran copolymer on oncogenic virus infections in immunosuppressed hosts.
    Hirsch MS; Black PH; Wood ML; Monaco AP
    J Immunol; 1972 May; 108(5):1312-8. PubMed ID: 4337673
    [No Abstract]   [Full Text] [Related]  

  • 28. [Presence of RNA-and DNA-tumor viruses within a cell line from mouse spleen and thymus (author's transl)].
    Widmaier R; Rudolph M; Fey F
    Arch Geschwulstforsch; 1975; 45(5):502-9. PubMed ID: 174519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro assessment of cellular immunity to Rauscher leukemia virus.
    Mortensen RF; Ceglowski WS; Friedman H
    J Immunol; 1973 Sep; 111(3):657-60. PubMed ID: 4741293
    [No Abstract]   [Full Text] [Related]  

  • 30. The phagocytic activity of the reticuloendothelial system of mice infected by Rauscher leukemia virus.
    Seidel HJ; Nothdurft W
    J Reticuloendothel Soc; 1976 Mar; 19(3):173-82. PubMed ID: 1263188
    [No Abstract]   [Full Text] [Related]  

  • 31. [On the pathodynamics of proliferative processes in the spleen of NMRI-mice during the early phase of Rauscher leukemia].
    Komitowski D; Goerttler K
    Exp Pathol (Jena); 1974; 9(3):182-90. PubMed ID: 4435093
    [No Abstract]   [Full Text] [Related]  

  • 32. Protection of C58 mice by normal murine tissues against transplantable leukemia, line Ib.
    Han IH; Johnson AG; Murphy WH
    J Natl Cancer Inst; 1969 May; 42(5):815-24. PubMed ID: 5785010
    [No Abstract]   [Full Text] [Related]  

  • 33. [Experiments for the demonstration of the Graffi leukemia virus in tissues of infected animals of various species].
    Micheel B; Pasternak G
    Arch Geschwulstforsch; 1968; 31(2):123-32. PubMed ID: 4299996
    [No Abstract]   [Full Text] [Related]  

  • 34. Morphology of BALB/c mice inoculated with Rauscher virus.
    Dunn TB; Green AW
    J Natl Cancer Inst; 1966 Jun; 36(6):987-1001. PubMed ID: 5944530
    [No Abstract]   [Full Text] [Related]  

  • 35. Pathogenesis of Rauscher leukemia.
    Boiron M; Levy JP; Lasneret J; Oppenheim S; Bernard J
    J Natl Cancer Inst; 1965 Nov; 35(5):865-84. PubMed ID: 5215384
    [No Abstract]   [Full Text] [Related]  

  • 36. Suppressive effect of leukemia virus-infected lymphoid cells on in vitro immunization of normal splenocytes.
    Kateley JR; Kamo I; Kaplan G; Friedman H
    J Natl Cancer Inst; 1974 Nov; 53(5):1371-8. PubMed ID: 4610168
    [No Abstract]   [Full Text] [Related]  

  • 37. [Mechanisms of the stimulating action of the Rauscher leukemia virus on togavirus reproduction in the bodies of BALB/c strain mice].
    Pogodina VV; Malenko GV; Levina LS; Karmysheva VIa; Farutina LM
    Vopr Virusol; 1980; (4):449-54. PubMed ID: 6158796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A transplantable leukemia from mice inoculated with Rauscher leukemia virus.
    Fredrickson TN; LoBue J; Alexander PA; Schultz EF; Gordon AS
    J Natl Cancer Inst; 1972 Jun; 48(6):1597-605. PubMed ID: 5056251
    [No Abstract]   [Full Text] [Related]  

  • 39. Natural immunity to grafts of FLD-3 erythroleukemia cells by irradiated mice.
    Afifi MS; Bennett M; Kumar V
    Nat Immun Cell Growth Regul; 1986; 5(4):200-10. PubMed ID: 2430178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity of subcellular fractions and molecular species of MuLV-induced tumors. II. Stimulation of syngeneic antitumor cell-mediated immune responses by subcellular fractions and molecular species of the Rauscher-virus-induced RBL5 tumor.
    Kobrin BJ; Naor D; Klein BY
    J Immunol; 1981 May; 126(5):1874-82. PubMed ID: 6260859
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.